Provided by Tiger Trade Technology Pte. Ltd.

AbbVie

255.00
+4.091.63%
Pre-market: 255.980.9800+0.38%04:18 EDT
Volume:4.40M
Turnover:1.12B
Market Cap:450.68B
PE:72.04
High:255.31
Open:251.23
Low:249.74
Close:250.91
52wk High:267.47
52wk Low:190.75
Shares:1.77B
Float Shares:1.76B
Volume Ratio:1.03
T/O Rate:0.25%
Dividend:6.83
Dividend Rate:2.68%
EPS(TTM):3.54
EPS(LYR):2.36
ROE:6225.00%
ROA:10.51%
PB:-75.94
PE(LYR):108.05

Loading ...

Abbvie : FY 2026 Adj EPS Guidance Includes $0.14 /Share Dilutive Impact Related to Acquisition of Apogee Therapeutics

THOMSON REUTERS
·
Jul 31

Abbvie Inc Q2 Global Skyrizi Revenue USD 5,505 Million

THOMSON REUTERS
·
Jul 31

Abbvie Inc Q2 Global Humira Revenue USD 756 Million

THOMSON REUTERS
·
Jul 31

Abbvie : Q2 Results Include an Unfavorable Impact of $0.17/Share Related to Acquired Ipr&D and Milestones Expense

THOMSON REUTERS
·
Jul 31

Abbvie Inc Outlook FY Adjusted EPS USD 0.14 VS. Ibes Estimate USD 14.1

THOMSON REUTERS
·
Jul 31

Abbvie Reports Second-Quarter 2026 Financial Results

THOMSON REUTERS
·
Jul 31

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Jul 31

U.S. Earnings Preview: Before Market Open July 31

Dow Jones
·
Jul 31

LIVE MARKETS-Yen Sinks as BOJ Holds - and It's the KOSPI's Best Day

Reuters
·
Jul 31

Morning BID EUROPE-Yen Sinks as BOJ Holds - and It's the KOSPI's Best Day

Reuters
·
Jul 31

AbbVie Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 31

AbbVie’s New Phase 1 ABBV-859 Trial: Early Pipeline Signal for Long-Term Investors

TIPRANKS
·
Jul 31

AbbVie’s ABBV-722 Clears Key Safety Hurdle in Contraceptive Interaction Study

TIPRANKS
·
Jul 31

Movement Alert|AbbVie Falls 3.15% in Regular Trading, Biotech Sector Selloff Compounds Pre-Earnings Pressure

Market Focus
·
Jul 30

July 2026's Top Stocks Believed To Be Trading Below Intrinsic Value

Simply Wall St.
·
Jul 29

AbbVie announces Elahere availability in Singapore

TIPRANKS
·
Jul 29

AbbVie announces European Commission approval for Rinvoq

TIPRANKS
·
Jul 29

AbbVie price target raised to $300 from $275 at Barclays

TIPRANKS
·
Jul 29

U.S. Research ROUNDUP-Boeing, Coca-Cola, PayPal

Reuters
·
Jul 29

AbbVie Says EU Approves Rinvoq for Non-segmental Vitiligo Treatment

Reuters
·
Jul 29